Helicobacter pylori (H. pylori) is a bacterial infection that is majorly found in patients suffering from gastric and duodenal ulcers.
Helicobacter pylori (H. pylori) is a bacterial infection that is majorly found in patients suffering from gastric and duodenal ulcers. Technological advancements and innovations in helicobacter pylori infection testing methodology providing accurate results and greater patient satisfaction would foster the industry growth.
The escalating prevalence of helicobacter pylori infection globally will positively influence the high adoption of non-invasive diagnostic solutions. According to the CDC, the prevalence of H. pylori infection globally is nearly 50% and approximately 80% to 90% in developing countries. The prevalence of helicobacter pylori infection is estimated between 35% and 40% in the U.S.
Reportedly, as per the American College of Gastroenterology (ACG) recommendations, a diagnostic test should be conducted to confirm the elimination of H. pylori infection prior to prescribing a proton pump inhibitor (PPI) to patients with no major symptoms such as odynophagia, gastrointestinal bleeding, anemia, early satiety, vomiting, progressive dysphagia, gastrointestinal cancer, and others. The surging incidences of gastric ulcer symptoms will augment demand for H. pylori testing in the forthcoming years.
According to a Global Market Insights, Inc., report, helicobacter pylori testing market size is estimated to surpass US$560 million by 2025. Described below are some factors driving the helicobacter pylori testing market trends.
Robust demand for serology test
Serologic test is considerably less expensive as compared to other available methodologies for detection of H. pylori infection. Numerous non-invasive tests such as stool antigen test (SAT), urea breath test (UBT), and others, are highly preferred over invasive methods that incorporate the utilization of endoscopy for biopsy.
These tests are highly suitable for testing on a large scale, while UBT is utilized to get accurate results. As the whole stomach is involved in UBT, this methodology is free from sampling errors.
High preference for rapid UBT
The urea breath test is widely utilized to detect current infection and get confirmation of successful elimination of H. pylori after the treatment. For example, the American Gastroenterological Association (AGA) also advocates stool antigen test and urea breath test as non-invasive active testing methods.
Consequently, the advantage of rapid diagnosis and the availability of cost-effective testing kits will propel high adoption of non-invasive methods in conducting testing procedures.
To access sample pages of this report titled, “Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/4408
Easy availability of point-of-care testing
Point-of-care testing (POCT) gives accurate results at an affordable price in a short time span. The companies functional in the helicobacter pylori testing market are emphasizing on developing sophisticated diagnostic kits. The enhancement of new products for helicobacter pylori tests will provide growth opportunities for the industry.
Persons with multiple health conditions are usually more vulnerable to infections and require early detection of diseases. Greater accessibility of point-of-care testing and easy availability of numerous invasive and non-invasive devices will positively impact business expansion.
High prevalence of H. pylori in MEA
The Middle East and Africa helicobacter pylori testing market are estimated to grow considerably at 7.9% CAGR up to 2025. The regional industry progress will be accelerated by development in infrastructure, improved healthcare facilities, and increasing healthcare expenditure in the region. As per the estimations by the United Nations, EMBASE & MEDLINE, the ratio of H. pylori infection in Africa accounted for a prevalence of 70% in 2015.
The ubiquity of peptic ulcers and cancer cases is expected to escalate high demand for H. pylori diagnosis in the continent. Additionally, rising government initiatives to conduct training sessions of human resources available for H. pylori testing solutions will encourage regional helicobacter pylori testing market growth in the coming years.
Several companies have recently developed their existing sequencing and analysis instruments in a bid to tackle the growing complexity of diseases. High demand to acquire sophisticated technologies, along with the presence of various firms offering innovative helicobacter pylori testing solutions would accelerate business growth. Some of the notable companies functional in the global helicobacter pylori testing market include Thermo Fisher, Quidel Corporation, Cardinal Health, Meridian Biosciences, Bio-Rad Laboratories, Inc., and Abbott.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com